On this episode of Making Money With Matt McCall, Matt invites back C. Scott Garliss. He’s one of the most plugged-in analysts at Stansberry Research and the editor of Stansberry NewsWire. They dive into earnings from semiconductor giant Nvidia (NVDA) and discuss what’s going on with the Federal Reserve and interest rates.
They also cover a big topic on Wall Street that’s not getting a lot of attention yet – new drugs being used to fight obesity. This is a huge epidemic that’s affecting millions of people around the world. And many pharmaceutical companies have jumped on the trend to develop drugs to fight against it. So, Scott shares two companies at the forefront of what could be a game changer in the fight against obesity.
#federalreserve #nvidia #inflation
00:00 Scott’s view on the Fed’s rate hikes
8:24 The S&P performance
11:00 The disconnect between reality and recession-looming rhetoric
14:06 Correlations between the Federal fund rates and the stock market
18:15 The prospect for the market in the next few months
19:57 The tech sector
22:04 Nvidia’s trend
22:56 Scott’s view on the healthcare sector
26:48 Scott’s long-term investment choice
➡️ Follow us on Facebook: https://www.facebook.com/StansberryResearch
➡️ Follow us on Twitter: https://twitter.com/stansberry
➡️ Follow us on Instagram: https://www.instagram.com/stansberry_research
➡️ Follow us on LinkedIn: https://www.linkedin.com/company/stanberry-research